Financial results

View our current and past quarterly and annual reports.

Financial Performance

Date Title Downloads

May 08 2024

Q1 2024 Report
PDF

Feb 29 2024

Full Year 2023 Report
PDF

Nov 02 2023

Q3 2023 Report
PDF

Aug 03 2023

Q2 2023 Report
PDF

May 09 2023

Q1 2023 Report
PDF

Mar 07 2023

Full Year 2022 Report
PDF

Nov 09 2022

Q3 2022 Report
PDF

Aug 08 2022

Q2 2022 Report
PDF

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.

Contact Investor Relations